|
Index of reports
> Cases with Breast Cancer (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Combipatch (Estradiol / Norethindrone) where reactions include breast cancer. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Combipatch side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-23
Patient: female, weighing 90.7 kg (199.5 pounds)
Reactions: Night Sweats, Contusion, Seborrhoeic Dermatitis, Urticaria, Urinary Incontinence, Blepharitis, Vaginal Haemorrhage, Mammogram Abnormal, Colonic Polyp, Smear Cervix Abnormal, Hot Flush, Upper Respiratory Tract Infection, Vitamin B12 Deficiency, Dyspepsia, Nodule, Epistaxis, Back Pain, Breast Cancer, Ventricular Extrasystoles, Cardiac Murmur, Pain in Extremity, Autonomic Nervous System Imbalance, Nasal Congestion, Breast Calcifications, Paraesthesia, Hirsutism, Diverticulum, Post-Traumatic Stress Disorder, Sleep Disorder, Acute Sinusitis, Helicobacter Gastritis, Bunion, Folliculitis, Adverse Drug Reaction, Cervicitis, Constipation, Abdominal Pain Upper, Cystocele, Lymphadenitis, Conjunctivitis Allergic, Dyspnoea Exertional, Fatigue, Chest Pain, Cholecystitis, Exostosis, Vulvovaginal Mycotic Infection, Supraventricular Extrasystoles, Febrile Neutropenia, Rhinorrhoea, Rash, Biopsy Breast, Hyperlipidaemia, Anxiety, Atrophic Vulvovaginitis, Syncope, Arthralgia, Diarrhoea, Bronchitis, Hypertension, Arthritis
Drug(s) suspected as cause:
Combipatch
Indication: Menopause
Medroxyprogesterone
Dosage: unk ukn, unk
Climara
Estraderm
Dosage: 0.1 mg, unk
Indication: Menopause
Start date: 1987-01-01
End date: 2004-08-01
Provera
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1995-01-01
End date: 1997-01-01
Other drugs received by patient: Femara; Paxil; Estrogens; Wellbutrin; Zithromax; Zoloft; Metronidazole; Percocet; Valtrex; Tussi-Organidin DM NR; Cyanocobalamin
Possible Combipatch side effects in female
Reported by a physician from United States on 2011-12-02
Patient: female, weighing 68.0 kg (149.7 pounds)
Reactions: Lymphadenopathy, Uterine Leiomyoma, Oedema Peripheral, Arteriosclerosis, Breast Pain, Breast Cancer, Cellulitis, Cardiac Murmur, Osteopenia, Hirsutism, Cerebral Small Vessel Ischaemic Disease, Metastases To Spine, Uterine Disorder, Scar, Bone Pain, Fall, Metastases To Lymph Nodes, Intervertebral Disc Disorder, Dizziness, Oedema, Abdominal Distension, Metastases To Peritoneum, Lymphoedema, Lymph Node Fibrosis, Breast Disorder, Musculoskeletal Pain, Cerebral Atrophy, Osteoarthritis, Anxiety, Mitral Valve Incompetence, Metastases To Bone, Deep Vein Thrombosis
Drug(s) suspected as cause:
Vivelle
Dosage: 0.05mg
Indication: Hormone Replacement Therapy
Start date: 1998-12-30
Combipatch
Dosage: 50/140mcg
Indication: Menopause
Start date: 1998-12-19
Gynodiol
Dosage: 1 mg, unk
Vivelle
Dosage: 0.025mg
Administration route: Topical
Prometrium
Dosage: 100mg
Indication: Hormone Replacement Therapy
Start date: 1998-12-30
Prempro
Dosage: 2.5mg
Indication: Menopause
Start date: 1998-03-13
Vagifem
Dosage: 25 ug, unk
Vivelle
Dosage: .075 mg, unk
Estradiol
Dosage: 1 mg, unk
Gynodiol
Dosage: 0.5 mg, unk
Indication: Hormone Replacement Therapy
Estradiol
Dosage: 0.5mg
Indication: Menopause
Start date: 1999-03-12
Other drugs received by patient: Aldactone; Wellbutrin; Femara; Remeron; Paxil; Dyazide; Spironolactone; Nolvadex; Prozac; Zyban; Xenical; Miacalcin; Aromasin; Alprazolam; Hydrochlorothiazide; Proventil; Zyrtec; Buspar
Possible Combipatch side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-20
Patient: female, weighing 95.2 kg (209.5 pounds)
Reactions: Osteoporosis, Perivascular Dermatitis, Radiation Skin Injury, Headache, Fall, Fibrocystic Breast Disease, Breast Cyst, Skin Lesion, Breast Cancer, Breast Pain, Breast Disorder, Post Herpetic Neuralgia, Breast Mass, Osteopenia, Rash, Breast Calcifications, Paraesthesia, Hyperlipidaemia, Burning Sensation, Breast Haemorrhage, Arthralgia, Nuclear Magnetic Resonance Imaging Abnormal, Breast Inflammation, Breast Fibrosis, Influenza Like Illness
Drug(s) suspected as cause:
Combipatch
Dosage: 0.5 mg, unk
Indication: Menopause
Start date: 2001-01-24
End date: 2005-01-03
Prempro
Administration route: Oral
Indication: Menopause
Start date: 1998-01-01
End date: 2000-12-01
Premarin
Administration route: Oral
Indication: Menopause
Start date: 1995-01-01
End date: 1997-12-01
Provera
Administration route: Oral
Indication: Menopause
Start date: 1995-01-01
End date: 1997-12-01
Other drugs received by patient: Lipitor; Atenolol
|
